Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
31st Congress of the European Society for Medical Oncology
Hormone-sensitive Breast Cancer Therapy Update: Long-term Findings from BIG 1-98
Istanbul, Turkey / September 29 - October 3, 2006
Istanbul - The greater efficacy of the third-generation aromatase inhibitors (AIs) letrozole, anastrozole and exemestane over tamoxifen in reducing the risk of breast cancer recurrence in the adjuvant setting has now been clearly...
31st Congress of the European Society of Medical Oncology
Metastatic Colorectal Cancer: New Directions in Systemic Treatment
Istanbul, Turkey / September 29-October 3, 2006
Istanbul - Delegates here learned about promising new chemotherapy regimens and biologic combinations during the scientific sessions. An important development in the chemotherapy regimens themselves for the treatment of metastatic...
31st Congress of the European Society of Medical Oncology
Treating Elderly Patients with Multiple Myeloma
Istanbul, Turkey / September 29-October 3, 2006
Istanbul - More than half of all cancer patients are over 65 years old at diagnosis and the proportion of elderly cancer patients will increase as the population ages. Treatment of the elderly presents unique challenges; for example, the...
61st Annual Meeting of the Canadian Urological Association
Preventing Prostate Cancer and Benign Prostatic Hyperplasia Progression
Halifax, Nova Scotia / June 25-28, 2006
Halifax - As discussed here this week, two pivotal trials that examined the effects of using 5-alpha reductase inhibitors in the management of patients with benign prostatic hyperplasia (BPH) are influencing clinical practice. The MTOPS...
11th Congress of the European Hematology Association
Non-Hodgkin’s Lymphoma: Building on the Evidence
Amsterdam, The Netherlands / June 15-18, 2006
Amsterdam - Non-Hodgkin’s lymphoma (NHL) encompasses a diverse group of malignancies, some of which are aggressive in nature, such as diffuse large B-cell lymphoma, as well as slower-growing indolent ones, such as follicular lymphoma....
83rd Canadian Paediatric Society Annual Conference
Reducing Disease Transmission and the Burden of Illness of Rotavirus and Human Papillomavirus
St. John’s, Newfoundland and Labrador / June 13-17, 2006
St. John’s - According to investigators, rotavirus is the most important cause of diarrhea in children in all regions of the world and across all socio-economic classes. Strict hygiene control, including fastidious hand washing, can help...
42nd Annual Meeting of the American Society of Clinical Oncology
Treatment Strategies for B-cell Chronic Lymphocytic Leukemia
Atlanta, Georgia / June 2-6, 2006
Atlanta - Chlorambucil, cyclophosphamide and fludarabine are considered first-line therapies for B-cell chronic lymphocytic leukemia (B-CLL). The goal of treatment is complete remission, with no evidence of minimal residual disease (MRD)....
42nd Annual Meeting of the American Society of Clinical Oncology
Targeted Therapy: A Treatment Advance in Renal Cell Carcinoma
Atlanta, Georgia / June 2-6, 2006
Atlanta - For the past two decades, the treatment of advanced renal cell carcinoma has been limited to two cytokines: interferon alpha (IFNa) and interleukin-2 (IL-2). IFNa is associated with an 11% response rate, while IL-2 has a response...
42nd Annual Meeting of the American Society of Clinical Oncology
The Role of Biomarkers and Monoclonal Antibodies in Lung Cancer
Atlanta, Georgia / June 2-6, 2006
Atlanta - Identifying patients who are more likely to respond to treatment is an important guiding principle in oncology, sparing those who are less likely to respond any unnecessary toxicity. In a subset of patients enrolled in the ECOG...